UBS analyst Taylor McGinnis maintains Coupa Software (NASDAQ:COUP) with a Neutral and lowers the price target from $84 to $76.
HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Raises Price Target to $36
HC Wainwright & Co. analyst Ed Arce maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $35 to $36.